Mtx325

Phase 1

MMission Therapeutics

Mtx325 is one of 5 therapeutic programs targeting Parkinson's Disease (PD). It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Parkinson's Disease (PD)Recruiting

Parkinson's Disease (PD)Phase 1

Recruiting

Competition

Competitive Landscape

8 competitors in Parkinson's Disease (PD)

#DrugCompanyPhaseTrials

Glucophage

EMD Serono

Approved

1 2

TJ0113

HHangzhou PhecdaMed Co., Ltd.

Phase 3

1 3

AAV2-Haadc

KKrzysztof Bankiewicz

Phase 1

1 4

Mtx325

MMission Therapeutics

Phase 1

1 5

Buntanetap/posiphen

AAnnovis Bio Inc.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Phase 1Recruiting

Parkinson's Disease (PD)

NCT07630545

Clinical

Trials by Indication[1]

Parkinson's Disease (PD)1 trial

A Multi-part, Adaptive Phase 1, First Time in Human Study in Healthy Volunteers to Assess Safety, Tolerability and Pharmacokinetics (PK) Following Single Ascending Dose (SAD) and Multiple Ascending Doses (MAD) of MTX325, Including Option to Assess: a Single Dose in Elderly Participants; Multiple Doses in Patients With Parkinson's Disease (PD); Central Nervous System (CNS) Penetration, Biodistribution, and Biomarkers; and the Effect of Food on PK.

Recruiting·MMission Therapeutics·Phase 1·NCT07630545·106 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Mtx325. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Mtx325. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Mission Therapeutics company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 1[1]
Company: MMission Therapeutics

Mtx325

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Parkinson's Disease (PD)1 trial

References

Drug Info

Quick Facts

Related News